289 related articles for article (PubMed ID: 30658474)
1. Adhesion Deregulation in Acute Myeloid Leukaemia.
Gruszka AM; Valli D; Restelli C; Alcalay M
Cells; 2019 Jan; 8(1):. PubMed ID: 30658474
[TBL] [Abstract][Full Text] [Related]
2. Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia.
Grenier JMP; Testut C; Fauriat C; Mancini SJC; Aurrand-Lions M
Front Immunol; 2021; 12():756231. PubMed ID: 34867994
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
[TBL] [Abstract][Full Text] [Related]
4. Targeting integrins in drug-resistant acute myeloid leukaemia.
Ogana HA; Hurwitz S; Wei N; Lee E; Morris K; Parikh K; Kim YM
Br J Pharmacol; 2024 Jan; 181(2):295-316. PubMed ID: 37258706
[TBL] [Abstract][Full Text] [Related]
5. Human acute myeloid leukaemia cells express adhesion proteins and bind to bone marrow fibroblast monolayers and extracellular matrix proteins.
Kortlepel K; Bendall LJ; Gottlieb DJ
Leukemia; 1993 Aug; 7(8):1174-9. PubMed ID: 8350618
[TBL] [Abstract][Full Text] [Related]
6. Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression.
Mendes M; Monteiro AC; Neto E; Barrias CC; Sobrinho-Simões MA; Duarte D; Caires HR
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674015
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche.
Boyd AL; Reid JC; Salci KR; Aslostovar L; Benoit YD; Shapovalova Z; Nakanishi M; Porras DP; Almakadi M; Campbell CJV; Jackson MF; Ross CA; Foley R; Leber B; Allan DS; Sabloff M; Xenocostas A; Collins TJ; Bhatia M
Nat Cell Biol; 2017 Nov; 19(11):1336-1347. PubMed ID: 29035359
[TBL] [Abstract][Full Text] [Related]
8. Proliferation and bone marrow engraftment of AML blasts is dependent on β-catenin signalling.
Siapati EK; Papadaki M; Kozaou Z; Rouka E; Michali E; Savvidou I; Gogos D; Kyriakou D; Anagnostopoulos NI; Vassilopoulos G
Br J Haematol; 2011 Jan; 152(2):164-74. PubMed ID: 21118196
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow mesenchymal/fibroblastic stromal cells induce a distinctive EMT-like phenotype in AML cells.
Nojszewska N; Idilli O; Sarkar D; Ahouiyek Z; Arroyo-Berdugo Y; Sandoval C; Amin-Anjum MS; Bowers S; Greaves D; Saeed L; Khan M; Salti S; Al-Shami S; Topoglu H; Punzalan JK; Farias JG; Calle Y
Eur J Cell Biol; 2023 Sep; 102(3):151334. PubMed ID: 37354622
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of primary acute myeloid leukaemia cell growth by lovastatin.
Newman A; Clutterbuck RD; Powles RL; Millar JL
Leukemia; 1994 Feb; 8(2):274-80. PubMed ID: 8309251
[TBL] [Abstract][Full Text] [Related]
11. The bone marrow microenvironment - Home of the leukemic blasts.
Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural changes during adhesion and migration of pre-B lymphoid leukaemia cells within bone marrow stroma.
Hewson J; Bianchi A; Bradstock K; Makrynikola V; Gottlieb D
Br J Haematol; 1996 Jan; 92(1):77-87. PubMed ID: 8562415
[TBL] [Abstract][Full Text] [Related]
13. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia.
Möhle R; Schittenhelm M; Failenschmid C; Bautz F; Kratz-Albers K; Serve H; Brugger W; Kanz L
Br J Haematol; 2000 Sep; 110(3):563-72. PubMed ID: 10997965
[TBL] [Abstract][Full Text] [Related]
14. Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?
Bernasconi P; Farina M; Boni M; Dambruoso I; Calvello C
Am J Hematol; 2016 May; 91(5):507-17. PubMed ID: 26822317
[TBL] [Abstract][Full Text] [Related]
15. The functional interplay of transcription factors and cell adhesion molecules in experimental myelodysplasia including hematopoietic stem progenitor compartment.
Daw S; Law S
Mol Cell Biochem; 2021 Feb; 476(2):535-551. PubMed ID: 33011884
[TBL] [Abstract][Full Text] [Related]
16. IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia.
Kuett A; Rieger C; Perathoner D; Herold T; Wagner M; Sironi S; Sotlar K; Horny HP; Deniffel C; Drolle H; Fiegl M
Sci Rep; 2015 Dec; 5():18411. PubMed ID: 26674118
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
Grove CS; Vassiliou GS
Dis Model Mech; 2014 Aug; 7(8):941-51. PubMed ID: 25056697
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukaemia niche regulates response to L-asparaginase.
Michelozzi IM; Granata V; De Ponti G; Alberti G; Tomasoni C; Antolini L; Gambacorti-Passerini C; Gentner B; Dazzi F; Biondi A; Coliva T; Rizzari C; Pievani A; Serafini M
Br J Haematol; 2019 Aug; 186(3):420-430. PubMed ID: 31044436
[TBL] [Abstract][Full Text] [Related]
19. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153
[TBL] [Abstract][Full Text] [Related]
20. [CXCR4: a new therapeutic target of the leukaemic cell? Role of the SDF-1/CXCR4 axis in acute myeloid leukaemia].
Tavernier E; Aanei C; Solly F; Flandrin-Gresta P; Campos L; Guyotat D
Bull Cancer; 2014 Jun; 101(6):593-604. PubMed ID: 24977448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
